Daniel Torres‐Moreno

Influence of polymorphisms and TNF and IL1β serum concentration on the infliximab response in Crohn’s disease and ulcerative colitis

Diana Lacruz-Guzmán, Daniel Torres‐Moreno, Francisco Pedrero et al. · European Journal of Clinical Pharmacology · 2012 · 93 citations

Inflammation, Chronic Inflammatory Diseases, Allergy +11

Effects of polymorphisms in TRAILR1 and TNFR1A on the response to anti-TNF therapies in patients with rheumatoid and psoriatic arthritis

María José Morales-Lara, Juan D. Cañete, Daniel Torres‐Moreno et al. · Joint Bone Spine · 2012 · 66 citations

Inflammation, Rheumatology, Anti-tnf Therapies +12

BARHL1 Is Downregulated in Alzheimer’s Disease and May Regulate Cognitive Functions through ESR1 and Multiple Pathways

Debmalya Barh, María Eulalia García-Solano, Sandeep Tiwari et al. · Genes · 2017 · 62 citations · Full text

Homeobox 1, Neurochemical Biomarkers, Cancer Biology +28

Expression profiling shows differential molecular pathways and provides potential new diagnostic biomarkers for colorectal serrated adenocarcinoma

Pablo Conesa‐Zamora, José García‐Solano, Francisco García‐García et al. · International Journal of Cancer · 2012 · 55 citations · Full text

A <i>FCGR3A</i> Polymorphism Predicts Anti-drug Antibodies in Chronic Inflammatory Bowel Disease Patients Treated With Anti-TNF

Patricia Romero-Cara, Daniel Torres‐Moreno, J.C. Pedregosa et al. · International Journal of Medical Sciences · 2017 · 43 citations · Full text